Cognitive Functioning/Dementia At least 5 studies (1 case-control, 1 cohort, 3 RCTs) discussed the role of GLP-1 agonists and their action in AD and dementia
For researchers using oral capsules, taking the compound 30 to 60 minutes before meals in a fasted state may enhance fat oxidation effects, though this recommendation is based on theoretical considerations rather than controlled studies
Willard FS, Douros JD, Gabe MBN, Showalter AD, Wainscott DB, Suter TM, et al
Not tested, not proven, not certified in terms of sterility and so on. Many peptides have weak evidence so proceed with caution What experts really worry about is that the success of some legitimate peptides have effectively served as a gateway drug to a whole new range of treatments with not only purity concerns, but flimsy evidence of their clinical value
India is now the third-largest obesity market in the world, trailing only the United States and China
Importantly for MCS, the two receptors modulate and sensitize each other